Characterizing emerging companies in computational drug development.
Nat Comput Sci
; 4(2): 96-103, 2024 Feb.
Article
em En
| MEDLINE
| ID: mdl-38413778
ABSTRACT
Computation promises to accelerate, de-risk and optimize drug research and development. An increasing number of companies have entered this space, specializing in the design of new algorithms, computing on proprietary data, and/or development of hardware to improve distinct drug pipeline stages. The large number of such companies and their unique strategies and deals have created a highly complex and competitive industry. We comprehensively analyze the companies in this space to highlight trends and opportunities, identifying highly occupied areas of risk and currently underrepresented niches of high value.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Algoritmos
/
Indústria Farmacêutica
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article